Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2015 Jun 12;59(7):4339–4342. doi: 10.1128/AAC.04854-14

Interspecies Transfer of the Penicillin-Binding Protein 3-Encoding Gene ftsI between Haemophilus influenzae and Haemophilus haemolyticus Can Confer Reduced Susceptibility to β-Lactam Antimicrobial Agents

Annette Søndergaard a, Elizabeth A Witherden b, Niels Nørskov-Lauritsen a,, Stephen G Tristram b
PMCID: PMC4468707  PMID: 25918135

Abstract

Mutations in ftsI, encoding penicillin-binding protein 3, can cause decreased β-lactam susceptibility in Haemophilus influenzae. Sequencing of ftsI from clinical strains has indicated interspecies recombination of ftsI between H. influenzae and Haemophilus haemolyticus. This study documented apparently unrestricted homologous recombination of ftsI between H. influenzae and H. haemolyticus in vitro. Transfer of ftsI from resistant isolates conferred similar but not identical increases in the MICs of susceptible strains of H. influenzae and H. haemolyticus.

TEXT

Haemophilus influenzae is the major human pathogen of the genus Haemophilus (1, 2), and infections are usually treated with β-lactam antimicrobial agents. Amino acid substitutions in penicillin-binding protein 3 (PBP3), encoded by the ftsI gene, can confer decreased susceptibility to β-lactams in strains lacking β-lactamase genes (3, 4). Genetically defined β-lactamase-negative ampicillin-resistant (gBLNAR) isolates carry either the N526K (Ubukata group II) or the R517H substitution in PBP3, while the additional substitutions S385T and/or L389F (Ubukata group III) further reduce susceptibility (3, 57). A range of other amino acid substitutions has been identified, but their significance is unclear (35, 8, 9).

Whether the worldwide spread of gBLNAR isolates is caused by clonal dissemination or horizontal gene transfer is controversial (8, 10, 11). H. influenzae and Haemophilus haemolyticus are close relatives, (1) and putative transfer of ftsI between these two species is indicated by mosaic structures of ftsI from clinical and nasopharyngeal carriage isolates (12, 13).

(Part of these data was presented on a poster at the 2014 International Pasteurellaceae Conference, Prato, Italy, 15 May 2014.)

The present study was undertaken to examine putative species barriers and delineate transformation events after ftsI transfer under standardized in vitro conditions. ftsI genes (1,833 bp) plus flanking regions from two gBLNAR H. influenzae strains and two gBLNAR H. haemolyticus strains were amplified by PCR (primers used for amplification and sequencing are listed in Table S1 in the supplemental material) and used for electroporetic transformation of susceptible strains of H. influenzae and H. haemolyticus (one representative each) as previously described (3). Characteristics of the donor and recipient strains are listed in Table 1, and overall similarity of ftsI and PBP3 are given in Table S2 in the supplemental material. Transformants were selected on chocolate agar (Columbia agar [Oxoid] supplemented with 5% horse blood and Vitox [Oxoid]) containing 0.5 μg/ml ampicillin (AMP) and screened for the presence of the N526K substitution using real-time PCR as previously described (14). We observed intraspecies ftsI transformation frequencies between 4.2 × 10−7 and 6.7 × 10−7 with H. influenzae strain Rd as the recipient and between 7 × 10−5 and 1 × 10−4 with H. haemolyticus strain ATCC 33390T as the recipient; we observed interspecies ftsI transformation frequencies between 3.3 × 10−7 and 1.7 × 10−6 with H. influenzae strain Rd as the recipient and between 1.6 × 10−5 and 2.4 × 10−5 with H. haemolyticus strain ATCC 33390T as the recipient. Thus, we observed no obvious difference in transformation frequencies of ftsI between strains of the same species and strains of separate species, although transformation occurred more frequently in H. haemolyticus recipient strain ATCC 33390T than in H. influenzae recipient strain Rd.

TABLE 1.

Bacterial strains used in this study

Strain Species Groupa Amino acid at positionb:
MIC rangec (μg/ml) of:
Reference or source
273 274 344 350 352 355 356 357 377 385 389 449 502 526 547 554 561 562 569 AMP CTX
Recipient
    Rd (KW20) H. influenzae S E K D T K V S M S L I A N V A A V N 0.125–0.19 0.008–0.016 18
    ATCC 33390T H. haemolyticus D R N G T V I I S 0.19–0.25 0.012–0.016 19
Donor
    ATCC 49247 H. influenzae II A K I T E S 3 0.19–0.25 19
    UTAS252 H. influenzae III N N I T F K I L S 0.5–1 0.5–1 This study
    L23 H. haemolyticus II N I V K I S 1.5–2 0.094–0.125 20
    L48 H. haemolyticus II D R N G T V I V K I S 1–1.5 0.012–0.023 20
a

ftsI mutation classification according to Ubukata et al. (3).

b

Amino acid (aa) positions of substitutions in the transpeptidase region (aa 265 to 580 of PBP3) relative to H. influenzae strain Rd (3). The critical mutations for group classification are in bold.

c

MIC range from two to four independent measurements.

Recombination events were delineated by sequencing the ftsI gene in five transformants of each recipient-donor combination. Mosaic structures of ftsI (Fig. 1) with sequence identities of >99.6% to the donor DNA in these segments documented homologous recombination in all 40 transformants. Recombination sites varied between recombinants of the same experiment and between different combinations of donor and recipient cells. Recombined fragments tended to be larger in intraspecies recombinations. When H. influenzae strain Rd was transformed with ftsI from H. influenzae strain ATCC 49247, all sequenced recombinants harbored almost the entire ftsI open reading frame (ORF) (1,833 nucleotides [nt]) of strain ATCC 49247 (Fig. 1A), while the recombined fragment varied from <600 to >1,500 nt when H. haemolyticus strain ATCC 33390T was transformed with the same DNA (Fig. 1B); however, even the smallest of these fragments encoded five (N526K, V547I, A554T, A561E, and N569S) of the six amino acid substitutions in the transpeptidase domain of PBP3 (see Fig. S1B in the supplemental material). The difference in size of the recombined fragments between intraspecies and interspecies recombinations was less prominent for other donor-recipient combinations (Fig. 1C to F). β-Lactams target the transpeptidase region of PBP3 that is encoded by nt 796 to 1,741 of ftsI (3). The entire transpeptidase region of the donor strain was present in almost all of the recombinants (Fig. 1).

FIG 1.

FIG 1

Schematic representation of single nucleotide polymorphisms (vertical lines) in donor H. influenzae (DHi) or donor H. haemolyticus (DHh) and recombinant strains relative to recipient strains (RHi or RHh). Left lane (A, C, E, G), intraspecies gene transfer; right lane (B, D, F, H), interspecies gene transfer. (A and B) H. influenzae strain ATCC 49247 donor; (C and D) H. influenzae strain UTAS252 donor; (E and F) H. haemolyticus strain L23 donor; (G and H) H. haemolyticus strain L48 donor. (A, C, F, and H) H. influenzae strain Rd recipient; (B, D, E, and G) H. haemolyticus strain ATCC 33390T recipient. White region, ftsI ORF; gray region, flanking regions. Numbers are relative to the first nucleotide of the ftsI ORF.

A previous comparison of ftsI sequences from clinical and surveillance strains of H. influenzae and H. haemolyticus clustered mosaic fragments of the gene into distinct groups of recombination profiles, indicating a preference for specific recombination events (13). In that analysis, there was no indication of horizontal transfer of the entire ORF of ftsI despite H. influenzae being capable of specific uptake and homologous recombination of segments in excess of 10 kb (15). In this in vitro study, we observed a wide variation in the size of recombined fragments, and for 8 of 40 recombinants, the entire ORF of ftsI was replaced. Moreover, the size and position of inserted fragments did not cluster into distinct groups of recombination profiles. The reason for these differences is not clear. We used electroporation to introduce DNA into recipient cells; hence, the recombined fragments did not depend on the specific uptake of genomic DNA fragments carrying the DNA uptake signal sequences that facilitates transformation in vivo (16). Also, we have no indication of the fitness of our recombinants when exposed to the selective forces of a commensal lifestyle. On the other hand, the apparent high frequency of interspecies recombination of ftsI in vivo (13) indicates events that may occur on multiple occasions, thereby blurring the origin of separate regions of the gene.

Ampicillin and cefotaxime (CTX) MICs were assessed using Etest (bioMérieux) on Mueller-Hinton agar (Oxoid) with 5% horse blood and HTM supplement (Oxoid). The results showed that transfer of segments of ftsI from gBLNAR strains conferred a rise in the AMP and CTX MICs for all recombinants (Table 2; see also Table S3A and B in the supplemental material). The increase in the AMP MIC was modest (3-fold to 6-fold increase) except when H. haemolyticus strain ATCC 33390T was transformed with the Ubukata group III ftsI gene from H. influenzae UTAS252; this transfer increased the AMP MIC of H. haemolyticus ATCC 33390T recombinants profoundly (13-fold), even surpassing the AMP MIC of the donor strain. The largest change in CTX susceptibility was also observed after transfer of the ftsI gene from strain UTAS252, which increased the CTX MICs of H. influenzae and H. haemolyticus recombinants more than 50 times (Table 2). Transfer of the Ubukata group II ftsI gene from H. influenzae strain ATCC 49247 ftsI altered the susceptibility of H. haemolyticus recombinants to a larger extent than that of the H. influenzae recombinants (6-fold and 9-fold versus 3-fold and 5-fold, respectively). Thus, ftsI from the same donor may alter the antimicrobial susceptibilities of the two species differently. The exceptionally high AMP MIC of the H. influenzae BLNAR reference strain ATCC 49247 was only partially transferred by horizontal transfer of ftsI (Table 2). The additional, non-PBP3 and non-β-lactamase resistance mechanisms have not been clearly identified (4, 17).

TABLE 2.

MICs of AMP and CTX for ftsI recombinants

Groupa Recombinant
AMP MIC (μg/ml)
CTX MIC (μg/ml)
Donor Recipient GMb Range Fold change GM Range Fold change
A ATCC 49247 H. influenzae strain Rd 0.47 0.25–0.75 3 0.056 0.032–0.094 5
B ATCC 49247 H. haemolyticus strain ATCC 33390T 1.35 1–2 6 0.118 0.064–0.19 9
C UTAS252 H. influenzae strain Rd 0.66 0.5–0.75 4 0.596 0.38–0.75 53
D UTAS252 H. haemolyticus strain ATCC 33390T 2.86 1.5–4 13 0.772 0.75–1 56
E L23 H. haemolyticus strain ATCC 33390T 1.11 0.5–2 5 0.047 0.012–0.094 3
F L23 H. influenzae strain Rd 0.53 0.25–1 3 0.034 0.012–0.064 3
G L48 H. haemolyticus strain ATCC 33390T 0.89 0.38–1.5 4 0.023 0.012–0.032 2
H L48 H. influenzae strain Rd 0.49 0.25–0.75 3 0.023 0.008–0.047 2
a

Letters relate to recombinant groups depicted in Fig. 1.

b

GM, geometric mean of five sequenced transformants, each determined twice in separate experiments.

The present study unambiguously documents intraspecies and interspecies recombination of ftsI in H. influenzae and H. haemolyticus in vitro, resulting in mosaic structures of the gene. Unexpectedly, the interspecies recombination of ftsI appeared relatively unaffected by the sequence divergence between the two species. However, phenotypic expression of the same ftsI gene may differ between H. haemolyticus and H. influenzae.

Supplementary Material

Supplemental material

ACKNOWLEDGMENTS

This work was supported by a grant from the Augustinus Foundation to A.S. and a grant from the Clifford Craig Medical Research Trust to S.G.T. and E.A.W.

Footnotes

Supplemental material for this article may be found at http://dx.doi.org/10.1128/AAC.04854-14.

REFERENCES

  • 1.Norskov-Lauritsen N. 2014. Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans. Clin Microbiol Rev 27:214–240. doi: 10.1128/CMR.00103-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Turk DC. 1984. The pathogenicity of Haemophilus influenzae. J Med Microbiol 18:1–16. doi: 10.1099/00222615-18-1-1. [DOI] [PubMed] [Google Scholar]
  • 3.Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, Sunakawa K, Inoue M, Konno M. 2001. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 45:1693–1699. doi: 10.1128/AAC.45.6.1693-1699.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tristram S, Jacobs MR, Appelbaum PC. 2007. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 20:368–389. doi: 10.1128/CMR.00040-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, Pasquier C. 2002. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 46:2208–2218. doi: 10.1128/AAC.46.7.2208-2218.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Osaki Y, Sanbongi Y, Ishikawa M, Kataoka H, Suzuki T, Maeda K, Ida T. 2005. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob Agents Chemother 49:2834–2839. doi: 10.1128/AAC.49.7.2834-2839.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Garcia-Cobos S, Campos J, Lazaro E, Roman F, Cercenado E, Garcia-Rey C, Perez-Vazquez M, Oteo J, de Abajo F. 2007. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 51:2564–2573. doi: 10.1128/AAC.00354-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Skaare D, Anthonisen IL, Caugant DA, Jenkins A, Steinbakk M, Strand L, Sundsfjord A, Tveten Y, Kristiansen BE. 2014. Multilocus sequence typing and ftsI sequencing: a powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae. BMC Microbiol 14:131. doi: 10.1186/1471-2180-14-131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Barbosa AR, Giufre M, Cerquetti M, Bajanca-Lavado MP. 2011. Polymorphism in ftsI gene and beta-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of beta-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid. J Antimicrob Chemother 66:788–796. doi: 10.1093/jac/dkq533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kishii K, Chiba N, Morozumi M, Hamano-Hasegawa K, Kurokawa I, Masaki J, Ubukata K. 2010. Diverse mutations in the ftsI gene in ampicillin-resistant Haemophilus influenzae isolates from pediatric patients with acute otitis media. J Infect Chemother 16:87–93. doi: 10.1007/s10156-009-0011-6. [DOI] [PubMed] [Google Scholar]
  • 11.Park C, Kim KH, Shin NY, Byun JH, Kwon EY, Lee JW, Kwon HJ, Choi EY, Lee DG, Sohn WY, Kang JH. 2013. Genetic diversity of the ftsI gene in beta-lactamase-nonproducing ampicillin-resistant and beta-lactamase-producing amoxicillin-/clavulanic acid-resistant nasopharyngeal Haemophilus influenzae strains isolated from children in South Korea. Microb Drug Resist 19:224–230. doi: 10.1089/mdr.2012.0116. [DOI] [PubMed] [Google Scholar]
  • 12.Takahata S, Ida T, Senju N, Sanbongi Y, Miyata A, Maebashi K, Hoshiko S. 2007. Horizontal gene transfer of ftsI, encoding penicillin-binding protein 3, in Haemophilus influenzae. Antimicrob Agents Chemother 51:1589–1595. doi: 10.1128/AAC.01545-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Witherden EA, Bajanca-Lavado MP, Tristram SG, Nunes A. 2014. Role of inter-species recombination of the ftsI gene in the dissemination of altered penicillin-binding-protein-3-mediated resistance in Haemophilus influenzae and Haemophilus haemolyticus. J Antimicrob Chemother 69:1501–1509. doi: 10.1093/jac/dku022. [DOI] [PubMed] [Google Scholar]
  • 14.Witherden EA, Kunde D, Tristram SG. 2013. PCR screening for the N526K substitution in isolates of Haemophilus influenzae and Haemophilus haemolyticus. J Antimicrob Chemother 68:2255–2258. doi: 10.1093/jac/dkt189. [DOI] [PubMed] [Google Scholar]
  • 15.Mell JC, Shumilina S, Hall IM, Redfield RJ. 2011. Transformation of natural genetic variation into Haemophilus influenzae genomes. PLoS Pathog 7:e1002151. doi: 10.1371/journal.ppat.1002151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Redfield RJ, Findlay WA, Bosse J, Kroll JS, Cameron AD, Nash JH. 2006. Evolution of competence and DNA uptake specificity in the Pasteurellaceae. BMC Evol Biol 6:82. doi: 10.1186/1471-2148-6-82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kaczmarek FS, Gootz TD, Dib-Hajj F, Shang W, Hallowell S, Cronan M. 2004. Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob Agents Chemother 48:1630–1639. doi: 10.1128/AAC.48.5.1630-1639.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496–512. doi: 10.1126/science.7542800. [DOI] [PubMed] [Google Scholar]
  • 19.ATCC. 2015. ATCC: the global bioresource center. ATCC, Manassas, VA: http://www.lgcstandards-atcc.org/ Accessed 7 April 2015. [Google Scholar]
  • 20.Witherden EA, Tristram SG. 2013. Prevalence and mechanisms of beta-lactam resistance in Haemophilus haemolyticus. J Antimicrob Chemother 68:1049–1053. doi: 10.1093/jac/dks532. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental material

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES